**Core Concept**
TB (tuberculosis) is a major public health concern worldwide, and its management requires a thorough understanding of its various treatment-resistant forms. XDR-TB (extensively drug-resistant tuberculosis) is a specific type of TB that has developed resistance to multiple drugs, making it challenging to treat.

**Why the Correct Answer is Right**
XDR-TB is defined by the World Health Organization (WHO) as TB that is resistant to at least four of the core anti-TB drugs, including isoniazid and rifampicin, as well as any fluoroquinolone and at least one of three injectable second-line drugs (i.e., amikacin, kanamycin, or capreomycin). This high level of resistance is due to the mutation of the bacterial DNA, which affects the functioning of these drugs. The presence of XDR-TB requires a multidisciplinary approach to treatment, including the use of second-line drugs and intensive patient monitoring.

**Why Each Wrong Option is Incorrect**
**Option A:** Monoresistance refers to TB that is resistant to only one anti-TB drug, which is not a characteristic of XDR-TB.
**Option B:** MDR-TB (multidrug-resistant tuberculosis) is a different form of TB that is resistant to at least isoniazid and rifampicin, but it does not involve the same level of resistance as XDR-TB.
**Option C:** Pre-XDR-TB refers to TB that is resistant to at least isoniazid and rifampicin, but not to a fluoroquinolone or an injectable second-line drug, which is a less severe form of resistance than XDR-TB.

**Clinical Pearl / High-Yield Fact**
It is essential to note that XDR-TB is often associated with a higher mortality rate and longer treatment duration compared to other forms of TB. Early detection and treatment are critical to preventing the spread of XDR-TB and improving patient outcomes.

**Correct Answer: D. TB that is resistant to at least four of the core anti-TB drugs, including isoniazid and rifampicin, as well as any fluoroquinolone and at least one of three injectable second-line drugs.**